[Federal Register Volume 84, Number 90 (Thursday, May 9, 2019)]
[Notices]
[Pages 20375-20376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (Working Group) will hold a 
meeting. The meeting will be open to the public. For this meeting, 
Working Group members will focus on plans to develop the next report to 
the HHS Secretary and Congress on federal tick-borne activities and 
research, taking into consideration the 2018 report. The 2020 report 
will also address a wide range of federal activities and research 
related to tick-borne diseases, such as, surveillance, prevention, 
diagnosis, diagnostics, and treatment; identify gaps in tick-borne 
disease research; and provide recommendations to the HHS Secretary 
regarding changes or improvements to such activities and research. In 
developing the report, the Working Group will solicit stakeholder 
input.

DATES: The meeting will be held on June 4, 2019, from 8:30 a.m. to 5:00 
p.m. ET (times are tentative and subject to change). The confirmed 
times and agenda items for the meeting will be posted on the website 
for the Working Group at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2019-6-4/index.html when this information 
becomes available.

ADDRESSES: The meeting will be held at the Holiday Inn Washington-
Capitol, 550 C Street SW, Washington, DC 20024. Members of the public 
may also attend the meeting via webcast. Instructions for attending via 
webcast will be posted one week prior to the meeting at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2019-6-4/index.html.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the Working Group; Office of HIV/AIDS and Infectious 
Disease Policy, Office of the Assistant Secretary for Health, 
Department of Health and Human Services, Mary E Switzer Building, 330 C 
Street SW, Suite L100, Washington, DC 20024. Email: 
[email protected]; Phone: 202-795-7697.

SUPPLEMENTARY INFORMATION: In-person attendance at the meeting is 
limited to space available; therefore, preregistration for public 
members is advisable and can be accomplished by

[[Page 20376]]

registering at https://www.eventbrite.com/e/tick-borne-disease-working-group-meeting-june-4-2019-meeting-9-tickets-60745681970. On the day of 
the meeting, seating will be provided first to persons who have 
preregistered. People who have not preregistered will be accommodated 
on a first come, first served basis if additional seats are still 
available 10 minutes before the meeting starts. Non-U.S. citizens who 
plan to attend in person are required to provide additional information 
and must notify the Working Group support staff via email at 
[email protected] before May 4, 2019.
    The public will have an opportunity to present their views to the 
Working Group during the meeting's public comment session or by 
submitting their views in writing. Comments should be pertinent to the 
meeting discussion. Persons who wish to provide in-person or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2019-6-4/index.html and 
respond by midnight Tuesday, May 28, 2019, ET. In-person comments will 
be limited to three minutes each to accommodate as many speakers as 
possible during the 30 minute session. Written public comments will be 
accessible to the Working Group members and public on the Working Group 
web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to tick-borne diseases to help ensure interagency 
coordination and minimize overlap, examine research priorities, and 
identify and address unmet needs. The Working Group is required to 
submit a report to the HHS Secretary and Congress on their findings and 
any recommendations for the federal response to tick-borne disease 
every two years.

    Dated: April 26, 2019.
James Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Senior 
Advisor for Blood and Tissue Policy, Office of HIV/AIDS and Infectious 
Disease Policy.
[FR Doc. 2019-09545 Filed 5-8-19; 8:45 am]
 BILLING CODE 4150-28-P